Boston Scientific Profit Margin

As of the most recent data (March 2026), BSX shows a profit margin of 17.25%. That compares with 11.58% in the prior-year period — up 49.0% year over year. That is above the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSX's profit margin is now 17.25% (was 11.58%) — a 49.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Boston Scientific is outperforming or lagging.

The Healthcare sector average profit margin is about 15.58%. Boston Scientific is at 17.25%, which is higher that average. That is roughly 10.7% above the sector mean. Use the comparison chart on this page to see how BSX stacks up against individual peers as well.

That compares with 11.58% in the prior-year period — up 49.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Boston Scientific with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Boston Scientific's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 17.25%) with ownership activity and broader fundamentals.